Accenture Healthcare global

Novartis

Data Lake / Data Warehouse Modernization · Real-time Analytics

Novartis needed to unify fragmented data across R&D, manufacturing, commercial, and corporate functions so teams could analyze growing biomedical and operational data sets faster and apply AI to drug development and patient operations.

10 days to three days
20% faster than legacy systems
36 are under development
Eleven use cases have been rolled out

Reported impact

Business outcome

Novartis accelerated analytics use-case development, gave global teams governed access to richer data, and built an AI-ready platform that supports faster decision making, broader experimentation, and more scalable innovation across the enterprise.

  • Productivity Improvement
  • Scalability
  • Speed to Market

Solution

Accenture helped Novartis design and implement a multi-cloud data analytics platform that consolidates enterprise data for AI- and analytics-driven decision making. The program established the data and analytics operating model, governance framework, roadmap, centralized data catalogue, and platform architecture, using Amazon Web Services as the primary cloud provider and Microsoft Azure as a secondary cloud environment. The platform ingests, unifies, and refines internal and external data from more than 80 sources across Development, Commercial, Manufacturing and Quality, and Corporate Business Services. Standardized data is then exposed to analytics tools and AI/ML workloads that simplify reporting, speed experimentation, and support cross-functional use cases such as clinical trial risk monitoring and patient-services analysis. By combining large-scale ingestion, governed cataloging, multi-cloud processing, and self-service analytics, Novartis created a reusable data foundation for faster innovation and broader application of AI across the business.

Data flow

Internal and external data from more than 80 sources is ingested into the multi-cloud platform, standardized through shared governance and cataloging, and then exposed to analytics and AI/ML tools. Teams across R&D, commercial, manufacturing, and business services use the resulting data products for reporting, experimentation, and operational decision making.

Solution architecture

5 components · 4 layers
  1. Compute
    • Amazon Web Services (AWS) Acts as the primary cloud provider for large-scale ingestion, storage, and analytics processing.
    • Microsoft Azure Extends the platform with secondary multi-cloud capabilities across additional functions and workloads.
  2. Storage
    • multi-cloud data analytics platform Provides the shared enterprise environment where Novartis consolidates, standardizes, and analyzes data across functions.
  3. Serving
    • analytics tools supported by AI and ML Enable reporting, experimentation, and operational use cases such as trial-risk monitoring and patient-services analysis.
  4. Governance
    • centralized data catalogue Gives teams governed visibility into enterprise data assets and supports standardized reuse.

Architecture clues

  • AWS is the primary cloud provider and Azure extends the platform as a secondary cloud.
  • The platform spans Development, Commercial, Manufacturing and Quality, and Corporate Business Services.
  • The program established a centralized data catalogue and data-governance operating model.

Evidence from the source

"Teams now have a smorgasbord of analytics tools, supported by AI and ML"
"The platform ingests, unifies and refines more than 9TB of internal and external data from over 80 sources"
"Working with Amazon Web Services (AWS) as the primary cloud provider, Novartis also engaged Microsoft Azure to create a multi-cloud platform"
"created the data and analytics operating model, governance, road map, architecture, centralized data catalogue and platform"
Transparency Evidence & methodology 100/100 reference value · 89% confidence · 1 source

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value100/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    3 metrics describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence89%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability19/25
    9 of 12 key fields link to a named source.
  • Direct evidence20/20
    4 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency10/10
    1 source reference document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. Accenture

    Life Sciences Digital Transformation | Novartis Case Study | Accenture

    First-party
    https://www.accenture.com/en/case-studies/life-sciences/reimagining-medicine-through-data-led-transformation
    Source type
    Vendor-published customer story
    Published
    Aug 14, 2026
    Supports
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date

Date evidence

  • Published on source page Aug 14, 2026 · Accenture · First-party
    Open date source
Not separately sourced Customer, Industry, Region, Company size. Treat these normalized attributes as lower-confidence until a dedicated source is added.